{"id":19934,"date":"2019-03-18T12:32:47","date_gmt":"2019-03-18T12:32:47","guid":{"rendered":"https:\/\/positivelysharing.wordpress.com\/?p=19934"},"modified":"2019-03-18T12:32:47","modified_gmt":"2019-03-18T12:32:47","slug":"omega-diagnostics-receives-ce-mark-for-hiv-monitoring-test","status":"publish","type":"post","link":"https:\/\/positivelysharing.org\/blog\/2019\/03\/18\/omega-diagnostics-receives-ce-mark-for-hiv-monitoring-test\/","title":{"rendered":"Omega Diagnostics Receives CE-Mark For HIV Monitoring Test"},"content":{"rendered":"<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span><p><img decoding=\"async\" src=\"https:\/\/www.burnet.edu.au\/system\/news_article\/image\/905\/VISITECT-CD4-test-510x288.jpg\" alt=\"Image result for VISITECT CD4 Advanced Disease\" \/>Omega Diagnostics Group PLC on Monday said it CE-marked its VISITECT CD4 Advanced Disease test for monitoring people living with HIV.<\/p>\n<div>\n<div id=\"div-gpt-ad-1353927354827-2\">\n<div id=\"google_ads_iframe_\/1036221\/lse_news_mpu_0__container__\"><span style=\"color:var(--color-neutral-600);\">The company said that the technical file supporting the CE-Mark will form the basis of the additional regulatory approvals that it will seek through the UNITAID-funded Expert Review Panel for Diagnostics hosted by the Global Fund to Fight AIDS, Tuberculosis and Malaria. <a href=\"http:\/\/www.lse.co.uk\/AllNews.asp?code=gmetbsfo&amp;headline=Omega_Diagnostics_Receives_CEMark_For_HIV_Monitoring_Test_\">Read More<\/a><\/span><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span>Omega Diagnostics Group PLC on Monday said it CE-marked its VISITECT CD4 Advanced Disease test for monitoring people living with HIV. The&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"post-19934","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-hiv"},"jetpack_featured_media_url":"","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/19934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/comments?post=19934"}],"version-history":[{"count":0,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/19934\/revisions"}],"wp:attachment":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media?parent=19934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/categories?post=19934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/tags?post=19934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}